Baek H, Han E, Oh K
Clin Exp Otorhinolaryngol. 2024; 17(4):326-335.
PMID: 39639713
PMC: 11626098.
DOI: 10.21053/ceo.2024.00164.
Ozdas T, Ozdas S, Canatar I, Kaypak E
Turk J Biol. 2024; 48(5):319-337.
PMID: 39474042
PMC: 11518375.
DOI: 10.55730/1300-0152.2708.
von Fournier A, Wilhelm C, Tirtey C, Stoth M, Ehret Kasemo T, Hackenberg S
Cancer Genomics Proteomics. 2024; 21(6):591-607.
PMID: 39467631
PMC: 11534036.
DOI: 10.21873/cgp.20476.
Jang J, Kang D, Lee Y, Lee Y
Int J Mol Sci. 2024; 25(19).
PMID: 39409154
PMC: 11476670.
DOI: 10.3390/ijms251910825.
von Fournier A, Ehret Kasemo T, Hackenberg S, Wilhelm C, Meyer T, Gehrke T
Oncol Lett. 2024; 28(2):400.
PMID: 38979554
PMC: 11228920.
DOI: 10.3892/ol.2024.14533.
A Tissue Engineered 3D Model of Cancer Cell Invasion for Human Head and Neck Squamous-Cell Carcinoma.
Stoth M, Mineif A, Sauer F, Meyer T, Mueller-Diesing F, Haug L
Curr Issues Mol Biol. 2024; 46(5):4049-4062.
PMID: 38785518
PMC: 11119844.
DOI: 10.3390/cimb46050250.
Investigation of Photodynamic Therapy Promoted by Cherenkov Light Activated Photosensitizers-New Aspects and Revelations.
Hubinger L, Wetzig K, Runge R, Hartmann H, Tillner F, Tietze K
Pharmaceutics. 2024; 16(4).
PMID: 38675195
PMC: 11054706.
DOI: 10.3390/pharmaceutics16040534.
Establishment and characterization of a novel hypopharyngeal squamous cell carcinoma cell line CZH1 with genetic abnormalities.
Ma J, Zhu X, Heng Y, Ding X, Tao L, Lu L
Hum Cell. 2024; 37(2):546-559.
PMID: 38280070
DOI: 10.1007/s13577-024-01026-5.
Combining Cisplatin with Different Radiation Qualities-Interpretation of Cytotoxic Effects In Vitro by Isobolographic Analysis.
Runge R, Reissig F, Herzog N, Oehme L, Brogsitter C, Kotzerke J
Pharmaceuticals (Basel). 2023; 16(12).
PMID: 38139846
PMC: 10746989.
DOI: 10.3390/ph16121720.
Copy Number Variation That Influences the Ionizing Radiation Sensitivity of Oral Squamous Cell Carcinoma.
Izumi T, Rychahou P, Chen L, Smith M, Valentino J
Cells. 2023; 12(20).
PMID: 37887269
PMC: 10605269.
DOI: 10.3390/cells12202425.
Community-engaged basic science in an NCI-designated comprehensive cancer center: antioxidants and chemotherapeutic efficacy.
Bollino D, Woodard N, Tighe K, Ma X, Casildo A, DAdamo C
Cancer Causes Control. 2023; 35(3):417-427.
PMID: 37812336
DOI: 10.1007/s10552-023-01806-8.
Epiberberine suppresses the metastasis of head and neck squamous cell carcinoma cells by regulating the MMP-13 and JNK pathway.
Ho H, Chen M, Lin C, Lo Y, Chuang Y, Hsieh M
J Cell Mol Med. 2023; 27(23):3796-3804.
PMID: 37710409
PMC: 10718148.
DOI: 10.1111/jcmm.17954.
Bioengineering of a tumour-stroma 3D-tumouroid co-culture model of hypopharyngeal cancer.
Saha S, Howarth R, Sharma-Saha S, Kelly C
Biol Open. 2023; 12(5).
PMID: 37194999
PMC: 10214853.
DOI: 10.1242/bio.059949.
Molecular Signature of Long Non-Coding RNA Associated with Areca Nut-Induced Head and Neck Cancer.
Huang H, You G, Tang S, Chang J, Cheng A
Cells. 2023; 12(6).
PMID: 36980216
PMC: 10047708.
DOI: 10.3390/cells12060873.
Exploiting Vitamin D Receptor and Its Ligands to Target Squamous Cell Carcinomas of the Head and Neck.
Koll L, Gul D, Elnouaem M, Raslan H, Ramadan O, Knauer S
Int J Mol Sci. 2023; 24(5).
PMID: 36902107
PMC: 10002563.
DOI: 10.3390/ijms24054675.
Psoralen as a Photosensitizers for Photodynamic Therapy by Means of In Vitro Cherenkov Light.
Hubinger L, Runge R, Rosenberg T, Freudenberg R, Kotzerke J, Brogsitter C
Int J Mol Sci. 2022; 23(23).
PMID: 36499568
PMC: 9735954.
DOI: 10.3390/ijms232315233.
The Vitamin D Receptor-BIM Axis Overcomes Cisplatin Resistance in Head and Neck Cancer.
Khamis A, Gul D, Wandrey M, Lu Q, Knauer S, Reinhardt C
Cancers (Basel). 2022; 14(20).
PMID: 36291915
PMC: 9600548.
DOI: 10.3390/cancers14205131.
Developing a Method to Estimate the Downstream Metabolite Signals from Hyperpolarized [1-C]Pyruvate.
Hsieh C, Sung C, Shen Y, Lai Y, Lu K, Lin G
Sensors (Basel). 2022; 22(15).
PMID: 35897987
PMC: 9332172.
DOI: 10.3390/s22155480.
Polyethylene Glycol 3350 (PEG 3350) as a Practical Vehicle for Rapid Reconstitution of PARPi-FL Formulations for Clinical Use.
Demetrio de Souza Franca P, Viray T, Roberts S, Michel A, Abrahao M, Patel S
Mol Imaging Biol. 2022; 25(2):294-302.
PMID: 35882728
PMC: 11225571.
DOI: 10.1007/s11307-022-01756-8.
Primary cold atmospheric plasma combined with low dose cisplatin as a possible adjuvant combination therapy for HNSCC cells-an in-vitro study.
Brunner T, Probst F, Troeltzsch M, Schwenk-Zieger S, Zimmermann J, Morfill G
Head Face Med. 2022; 18(1):21.
PMID: 35768853
PMC: 9245296.
DOI: 10.1186/s13005-022-00322-5.
